## output-ind

This is the Claude Code (Opus 4.8, 1M context, Ultracode) narrative output for the
*Phase 1 PDAC IND: AI Generation* build (IND v1.0, repository v4.3.0). It records
the build narrative only; the code files live in their stage directories.

### Approach

I read the inputs and prior developments first: the ReGARDD IND template
(`trial-ind/inputs/ReGARDD_IND_Template.docx`, whose Table of Contents and Cover
Letter / FDA 1571 ordering I followed exactly), the FDA Form 1571 instructions, the
ReGARDD academic-research guidance, the Phase 1 protocol
(`trial-protocol/final-protocol/publication`), the acceleration paper
(`trial-documents/final-paper/publication`), the PI large-document guidance
(`trial-documents/inputs/llm-adoption`), and the paper template
(`regulatory/Adaption-21-CFR-Part-312/source/Physical_AI_21_CFR_Part_312.sty`). I
built a grayscale `indstyle.sty` from that template merged with the senior-author
formatting primitives proven in the protocol and paper styles, keeping the current
template color (black body text) and recoloring only the figures, to a strictly
grayscale eight-tone ramp.

The build follows the `trial-protocol` processing workflow, adapted to the IND: one
master prompt drives Process A (write the four stage sub-prompts) and then Process B
(execute them as Stages 1 to 4). Every generated file was committed and pushed to
the working branch in real time so the branch is monitorable without intervention.

### Milestones

- M0 Bootstrap. Filed the master prompt verbatim (`prompts/prompt-ind.md`), wrote
  the four stage sub-prompts (`sub-prompts/prompt-1-mermaid` through
  `prompt-4-final-ind`), the build-hub README, and the prompts, sub-prompts, and
  inputs READMEs.

- M1 Stage 1 mermaid. Produced 22 new grayscale Mermaid figures, one commit per
  figure. The catalog blends the IND-acceleration process (adapting, in context and
  recolored to grayscale, the source-paper Figures 6, 9, 11, 15, 16, 17, 19, 20, 23,
  24) with the IND clinical and regulatory content (the drug mechanism, the 3+3 dose
  escalation, CMC, pharmacology and toxicology, the perioperative advisory, the
  safety-reporting triggers, governance, the objective-to-endpoint hierarchy, and
  the previous human experience). Each figure names its source files (Rule 5). I
  validated every file for balanced fences, present `classDef` sets, and resolved
  `:::class` references, then shipped the inventory README and `output-mermaid.md`.

- M2 Stage 2 draft-ind. Wrote `main.tex` (the COVER PAGE block, the ReGARDD ordering
  with the Cover Letter and FDA 1571 ahead of a numbered Table of Contents so the
  Introduction is section 3, and `\clearpage` per section), `indstyle.sty`,
  `references.bib`, the README, and twelve `sections/sec-*.tex` scaffolds filled with
  bracketed `[DRAFTING INSTRUCTION]` markers that name the exact repository files the
  later stages process. Static checks confirmed balanced braces, present inputs, and
  no en-dashes or em-dashes. Shipped `draft-ind-LaTeX.zip` and `output-draft-ind.md`.

- M3 Stage 3 full-ind. Generated the twelve full sections (about 315,000
  characters) with 20 TikZ `mermaidfig` figures and 31 full-width tables carrying the
  quantitative trial data. The error-fix pass repaired one missing `\end{table}` and
  verified environment balance, captions inside floats, valid citation keys, no
  nested `tikzpicture`, and no stray dashes. Shipped `full-ind-LaTeX.zip` and
  `output-full-ind.md`.

- M4 Stage 4 final-ind. Brought the IND to maximum quality: deepened the prose to
  about 597,000 characters (the package reaches about ten times the source paper),
  unified the figure numbering into a single Figure 1 to 22 sequence (rendering all
  22 figures, with a duplicate governance figure removed and cross-referenced),
  numbered tables in section sequences, and applied the senior-author white-space
  polish (`\clearpage` per self-standing section, `\needspace` before floats, tuned
  ragged-right full-width table widths, no stranded or one-to-two-word lines, single
  dashes, the section symbol for codified references). A geometric scan of all 22
  figures found zero horizontal box-overlap pairs. Shipped `final-ind-LaTeX.zip` and
  `output-final-ind.md`. There is no `publication` subdirectory under `final-ind`.

- M5 Release v4.3.0. Updated the root `README.md` (new badges, a 425-character
  summary, a dedicated v4.3.0 section with a grayscale build diagram and the
  stage-outputs and IND-at-a-glance tables, and the `trial-ind/` repository-structure
  subtree), `CHANGELOG.md`, `releases.md`, and this `output-ind.md`. The build adds
  only `.tex`, `.md`, `.sty`, `.bib`, and `.zip` files (no Python or YAML), so the
  `lint-and-format` checks (`ruff check`, `ruff format`, `yamllint`) on Python 3.10,
  3.11, and 3.12 remain green.

### Result

A complete, comprehensive Phase 1 PDAC IND following the ReGARDD Table of Contents,
with 22 grayscale figures reproduced exactly from Mermaid to LaTeX, about 90
full-width tables, and the daraxonrasib and eight-arm robotic Whipple data needed for
Phase 1 review, produced under one prompt with every file committed to GitHub in real
time. The DOI `10.5281/zenodo.xxxxxxxx` is a placeholder pending deposit. This is an
independent research paper and practical adoption guide, not medical or regulatory
advice, and is not endorsed by the FDA, NIH, HHS, an IRB, ICH, or any sponsor.
